EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS073-13441 
Organism
Homo sapiens 
Tissue/cell
GM19238 
Coordinate
chr7:102084710-102086340 
Target genes
TF binding sites/motifs
Number: 11             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EWSR1-FLI1MA0149.1chr7:102086244-102086262TTTTGTTTCCTTCCTTCC-6.4
EWSR1-FLI1MA0149.1chr7:102086260-102086278CCTTCCTCCCTCCCTCCC-7.28
EWSR1-FLI1MA0149.1chr7:102086256-102086274CCTTCCTTCCTCCCTCCC-8.32
EWSR1-FLI1MA0149.1chr7:102086248-102086266GTTTCCTTCCTTCCTTCC-9.07
EWSR1-FLI1MA0149.1chr7:102086252-102086270CCTTCCTTCCTTCCTCCC-9.47
IRF1MA0050.2chr7:102086301-102086322TCCTTCTTTCTTTTTCTTTTC+6.16
Nr2f6(var.2)MA0728.1chr7:102085332-102085347TGAACTCCTGACCTC-6.22
RREB1MA0073.1chr7:102084943-102084963CCCCCCCCCGCCCCCCACCC+6.27
ZNF263MA0528.1chr7:102086259-102086280TCCTTCCTCCCTCCCTCCCTT-6.46
ZNF263MA0528.1chr7:102086255-102086276TCCTTCCTTCCTCCCTCCCTC-6.86
ZNF263MA0528.1chr7:102086251-102086272TCCTTCCTTCCTTCCTCCCTC-7.08
Number of super-enhancer constituents: 12             
IDCoordinateTissue/cell
SE_10269chr7:102085085-102086094CD19_Primary
SE_11022chr7:102080216-102088535CD20
SE_32635chr7:102081226-102086421GM12878
SE_43600chr7:102080345-102088157MM1S
SE_50775chr7:102085311-102085834Sigmoid_Colon
SE_53584chr7:102085316-102085958Spleen
SE_58603chr7:102040407-102092313Ly1
SE_59253chr7:102055636-102092627Ly3
SE_60478chr7:102022497-102092339DHL6
SE_62031chr7:102047957-102092277Toledo
SE_62443chr7:102048336-102086597Tonsil
SE_67206chr7:102080345-102088157MM1S
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr7102085418102085789
chr7102085200102086165
Number: 1             
IDChromosomeStartEnd
GH07I102444chr7102085043102086262
Enhancer Sequence
TTTTTTTGTG GCAGGGTCTC ACTCTGTCTC CCAGGCTGGA GTGCAGTGGC ATGATCTCAG 60
CTCACTGAAA CCCCTGCCCG CCAGATTCAA GCGATTCTCC TGCCTCAGCC TCCCAAGTAG 120
CTGGGATTAC AGGCACGAGC CACCATGCCC GGTTCATTTT TGTATTTTTC ACAGAGAAAG 180
AGTTTTGCCA TATTGGCCAG GCTGGTCTCC AACTCCTGAC CTCAAGTGAT CCGCCCCCCC 240
CCGCCCCCCA CCCTCCAGCC TCTTAAAGTG CTGGGATTAC AGGCATGAGC CACCGCACCT 300
GGCCTGAGTT TTGTTGTTTT TTTTTCTTTA AACAGGGATG GCTTAGGTCT AGGAGGGAAA 360
CAGTGGAAAC AGTGGGTAGA AGAACCTTCC CCAGGCTTCT TCTTTTTTTT TTTTTTTTTT 420
GAGACAAAGT CCTGCTCTGT CACTTAGGCT GGAGTGCAGT GGCATGATCT CCATTCACTG 480
CAACCTCTGC TTCCTAGGTT CAAGTGATTC TCCTGCCTCC GCTTCCTGAG TAGCTGGGAT 540
TACAGATGCC CACCACCACG TCCAGCTAAT TTTTTGTATT TTTAGTAAAG ACGGGGTTTC 600
ACCATGCGGG CCAGGCTGGT CTTGAACTCC TGACCTCAAG TGATCCACCC ACCTCGGCCT 660
CCCAAAGTGC TGGGATTATA GGTGTGAGCC ACCGCGCCTG GCTGACCTCA CATTTCAAGA 720
CACCAAGCAG AGCCTGCCGT TCCTTGGTTT GTTCGTTTTA GACTCTACCT GCTGTAGCCT 780
CCGACTACGG TTGATGATTT TGCTTCCTTA GCAGACCCAG CCATGCCTCC TTTCCACAGC 840
TTCCCTCCTC ACCCTCGGCC TCACTTCCGT CACCTTTCCC GAGCTTTAGA GATGCCGGCT 900
CTCACTGGGC TTTTGGCCTC TGCTGAGGAG GCACCATGTG GTCTGTCTGA GGCCATCCAG 960
GTGTGCAGCT CTGAGTCTGG GGACTCTCCG CACTTTCAGT TGTTCTGTTT TAAAAGGTCA 1020
GTTTCCGTTT TTTGTTTTTT TTTTTTGTCA AGATGGGCTG TCACTATGTT GCCTAGGCTG 1080
GTCTCAAACT CCTGGGCTCA AGCGATCCTC CTGCCTCTGC CTCCCAAAGT GCTGGGATTA 1140
CAGGCATGAA TCATCGTGCC TGGTCAGTTT TTACCTTTTG AAAGGTCAGT TTCCTTTTTT 1200
TGTAGAGACG AGGTCTCACT CTGTCACCCG GGCTGAAGTG TAGTGGTGTG ATCATAGCTC 1260
ACTGCAGCCT GTTATCTCCC GGGTTCAAGC GATCCTCCCA CCTCAGTCTC CTCAGTAGCT 1320
GGGACTACAG GCATGTGCCA CCATGCCCGG CTAATTTTGT ATTTTTTATA GAGACAGGGT 1380
CTCCTTCTGT CCCCCAGGCT GGAGTGCAGT GGTGCAATCG GGGCTCCCAG CAGCCTGGAA 1440
TTCCTGGCCT CAAGTGATCT TCCTGCCTCA ACCTCCCAAA CCACTGGGAT TACAGGCATG 1500
AACCATTGTA CCCAGCCAGT TTTTCACTTC TTTCTTTTGT TTCCTTCCTT CCTTCCTCCC 1560
TCCCTCCCTT TTCTCTTTCT TTTCTTTCTT TTCCTTCTTT CTTTTTCTTT TCTTTCTCTC 1620
TCTTTCTTTC 1630